Download PDF
A fairly recent but already fast-growing industry, the biotech sector seeks to claim a role in Europe as a catalyst for growth in the aftermath of the COVID-crisis.
The new Green Deal will have a direct impact on the ongoing negotiations about the post-2020 Common Agricultural Policy (CAP) as EU farmers will be asked to re-adjust the way they work to the new green objectives.
The discussion over the future of biotechnology in Europe heated up after the EU Court ruled in July last year that gene editing should, in principle, fall under the GMO Directive. We focus on the future of biotechnology in Europe, the regulatory framework of the so-called new plant-breeding techniques, as well as GMOs.
Biotechnology could help patients across Europe gain access to innovative therapies, for example, against rare diseases. Proponents of bio-medicines also claim that precision therapy, because it is more efficient, will ease the burden on member states’ ailing healthcare systems.
